HY-112066-100mg
|
MedChemexpress LLC
|
SHIN1 [CAS 2146095-85-2]
|
|
Cancer-programmed cell death
|
|
HY-112066-25mg
|
MedChemexpress LLC
|
SHIN1 [CAS 2146095-85-2]
|
|
Cancer-programmed cell death
|
|
HY-112066-5mg
|
MedChemexpress LLC
|
SHIN1 [CAS 2146095-85-2]
|
|
Cancer-programmed cell death
|
|
HY-112066-50mg
|
MedChemexpress LLC
|
SHIN1 [CAS 2146095-85-2]
|
|
Cancer-programmed cell death
|
|
HY-115510-10mg
|
MedChemexpress LLC
|
SPR inhibitor 3 [CAS 1292285-54-1]
|
|
COVID-19-immunoregulation
|
|
HY-115510-100mg
|
MedChemexpress LLC
|
SPR inhibitor 3 [CAS 1292285-54-1]
|
|
COVID-19-immunoregulation
|
|
HY-115510-5mg
|
MedChemexpress LLC
|
SPR inhibitor 3 [CAS 1292285-54-1]
|
|
COVID-19-immunoregulation
|
|
HY-115510-50mg
|
MedChemexpress LLC
|
SPR inhibitor 3 [CAS 1292285-54-1]
|
|
COVID-19-immunoregulation
|
|
HY-117724-10mg
|
MedChemexpress LLC
|
AZ3976 [CAS 1418747-15-5]
|
|
Neuroscience-Neuromodulation
|
|
HY-117724-100mg
|
MedChemexpress LLC
|
AZ3976 [CAS 1418747-15-5]
|
|
Neuroscience-Neuromodulation
|
|
HY-117724-25mg
|
MedChemexpress LLC
|
AZ3976 [CAS 1418747-15-5]
|
|
Neuroscience-Neuromodulation
|
|
HY-117724-5mg
|
MedChemexpress LLC
|
AZ3976 [CAS 1418747-15-5]
|
|
Neuroscience-Neuromodulation
|
|
HY-117724-50mg
|
MedChemexpress LLC
|
AZ3976 [CAS 1418747-15-5]
|
|
Neuroscience-Neuromodulation
|
|
HY-120635-10mg
|
MedChemexpress LLC
|
BMS-1001 (hydrochloride) [CAS 2113650-04-5]
|
|
Neuroscience-Neuromodulation
|
|
HY-120635-100mg
|
MedChemexpress LLC
|
BMS-1001 (hydrochloride) [CAS 2113650-04-5]
|
|
Neuroscience-Neuromodulation
|
|
HY-120635-25mg
|
MedChemexpress LLC
|
BMS-1001 (hydrochloride) [CAS 2113650-04-5]
|
|
Neuroscience-Neuromodulation
|
|
HY-120635-5mg
|
MedChemexpress LLC
|
BMS-1001 (hydrochloride) [CAS 2113650-04-5]
|
|
Neuroscience-Neuromodulation
|
|
HY-120635-50mg
|
MedChemexpress LLC
|
BMS-1001 (hydrochloride) [CAS 2113650-04-5]
|
|
Neuroscience-Neuromodulation
|
|
HY-120878-10mg
|
MedChemexpress LLC
|
CXCR2-IN-2 [CAS 1838123-21-9]
|
|
COVID-19-immunoregulation
|
|
HY-120878-100mg
|
MedChemexpress LLC
|
CXCR2-IN-2 [CAS 1838123-21-9]
|
|
COVID-19-immunoregulation
|
|
HY-120878-25mg
|
MedChemexpress LLC
|
CXCR2-IN-2 [CAS 1838123-21-9]
|
|
COVID-19-immunoregulation
|
|
HY-120878-5mg
|
MedChemexpress LLC
|
CXCR2-IN-2 [CAS 1838123-21-9]
|
|
COVID-19-immunoregulation
|
|
HY-120878-50mg
|
MedChemexpress LLC
|
CXCR2-IN-2 [CAS 1838123-21-9]
|
|
COVID-19-immunoregulation
|
|
HY-122026-10mg
|
MedChemexpress LLC
|
PF-04802367 [CAS 1962178-27-3]
|
|
Neuroscience-Neurodegeneration
|
|
HY-122026-100mg
|
MedChemexpress LLC
|
PF-04802367 [CAS 1962178-27-3]
|
|
Neuroscience-Neurodegeneration
|
|